Identification and Validation of FGF-Related Prognostic Signatures in Prostate Cancer.

Yongkang Ye Ru-Jun MoRuinian ZhengJun ZouShaoqian LiuQiwu Mi Wei-De Zhong

Published in: Disease markers (2023)

To summarize, our FGF-related risk signature may effectively predict and diagnose PCa, indicating that in PCa patients, they are potential therapeutic targets and promising prognostic biomarkers.

Keyphrases

prostate cancer
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
gene expression
genome wide
patient reported outcomes
human health